Wordt geladen...
A new approach to disease-modifying drug trials in Parkinson’s disease
Translating new findings in the laboratory into therapies for patients is a slow and expensive process. The development of therapies for neurodegenerative diseases is further complicated by the difficulty in determining whether the drug truly retards the slow degenerative process or provides only sy...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3668828/ https://ncbi.nlm.nih.gov/pubmed/23728166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69690 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|